
Limited Distribution and Data Capture
Leigh Ann Bruhn, director of Avalere Health, notes that limited distribution for specialty pharmaceuticals can improve a manufacturer's data capture capabilities.
Leigh Ann Bruhn, director of Avalere Health, notes that limited distribution for specialty pharmaceuticals can improve a manufacturer's data capture capabilities.
Bruhn refers to the results of the study "DIMENSIONS of Specialty Pharmaceuticals: Evolving Trends in Market Access," conducted by Avalere Health and commissioned by Janssen Biotech, Inc and Johnson & Johnson Health Care Systems.
For more information, read "Emerging Trends Affecting Market Access to Specialty Therapies" at
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































